Assessment of albumin and overall survival in advanced non-small cell lung cancer patients with anlotinib treatment using generalized additive model: A retrospective cohort study

Congyi Xie , Jinzhan Chen , Zhisheng Chen , Yijiao Xu , Jiaxin Liu , Huijun Zhang , Hongni Jiang , Feiyang Ye , Lin Tong
{"title":"Assessment of albumin and overall survival in advanced non-small cell lung cancer patients with anlotinib treatment using generalized additive model: A retrospective cohort study","authors":"Congyi Xie ,&nbsp;Jinzhan Chen ,&nbsp;Zhisheng Chen ,&nbsp;Yijiao Xu ,&nbsp;Jiaxin Liu ,&nbsp;Huijun Zhang ,&nbsp;Hongni Jiang ,&nbsp;Feiyang Ye ,&nbsp;Lin Tong","doi":"10.1016/j.ceh.2023.09.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Albumin is believed to be associated with the prediction of various cancers. This retrospective cohort study aimed to explore the non-linear relationship between albumin level and overall survival (OS) in advanced non-small cell lung cancer (NSCLC) patients with anlotinib therapy, utilizing the Generalized additive model (GAM) approach. Specifically, we investigated the potential non-linear associations that might not be captured by conventional linear analyses.</p></div><div><h3>Methods</h3><p>A retrospective cohort of 211 patients undergoing anlotinib treatment for advanced NSCLC was included in this study. A wide range of albumin levels was considered, and the GAM method was applied to account for potential confounding clinical variables and unveil the non-linear relationship between albumin and OS.</p></div><div><h3>Results</h3><p>A non-linear relationship with inflection points of 40 g/L and 48 g/L was detected between albumin level and OS after adjusting for potential confounders. The hazard ratio (HR) of the left, middle and right of the inflection points were 0.95 (95 % confidence interval [CI], 0.87 to 1.04, p = 0.2819, n = 71), 0.75 (95 % CI, 0.64 to 0.89, p = 0.0007, n = 133) and 2.79 (95 % CI, 1.39 to 5.61, p = 0.0039, n = 7), respectively. The findings indicate a negative correlation between albumin level and OS when albumin level was between 40 g/L and 48 g/L. For every unit increase in albumin, there was a 25 % reduction in the risk of death. Subgroup analysis revealed that the negative relationship was enhanced with blood urea nitrogen (BUN) level increase and diminished with D-dimer increase.</p></div><div><h3>Conclusions</h3><p>The relationship between albumin level and OS was non-linear. Albumin level is an independent prognostic factor for OS. In addition, BUN level and D-dimer level could modify the effect of albumin level on the risk of death in advanced NSCLC patients treated with anlotinib.</p></div>","PeriodicalId":100268,"journal":{"name":"Clinical eHealth","volume":"6 ","pages":"Pages 121-129"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical eHealth","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2588914123000242","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Albumin is believed to be associated with the prediction of various cancers. This retrospective cohort study aimed to explore the non-linear relationship between albumin level and overall survival (OS) in advanced non-small cell lung cancer (NSCLC) patients with anlotinib therapy, utilizing the Generalized additive model (GAM) approach. Specifically, we investigated the potential non-linear associations that might not be captured by conventional linear analyses.

Methods

A retrospective cohort of 211 patients undergoing anlotinib treatment for advanced NSCLC was included in this study. A wide range of albumin levels was considered, and the GAM method was applied to account for potential confounding clinical variables and unveil the non-linear relationship between albumin and OS.

Results

A non-linear relationship with inflection points of 40 g/L and 48 g/L was detected between albumin level and OS after adjusting for potential confounders. The hazard ratio (HR) of the left, middle and right of the inflection points were 0.95 (95 % confidence interval [CI], 0.87 to 1.04, p = 0.2819, n = 71), 0.75 (95 % CI, 0.64 to 0.89, p = 0.0007, n = 133) and 2.79 (95 % CI, 1.39 to 5.61, p = 0.0039, n = 7), respectively. The findings indicate a negative correlation between albumin level and OS when albumin level was between 40 g/L and 48 g/L. For every unit increase in albumin, there was a 25 % reduction in the risk of death. Subgroup analysis revealed that the negative relationship was enhanced with blood urea nitrogen (BUN) level increase and diminished with D-dimer increase.

Conclusions

The relationship between albumin level and OS was non-linear. Albumin level is an independent prognostic factor for OS. In addition, BUN level and D-dimer level could modify the effect of albumin level on the risk of death in advanced NSCLC patients treated with anlotinib.

应用广义加性模型评估晚期非小细胞肺癌患者接受安洛替尼治疗的白蛋白和总生存率:一项回顾性队列研究
背景白蛋白被认为与各种癌症的预测有关。这项回顾性队列研究旨在利用广义加性模型(GAM)方法,探讨接受安洛替尼治疗的晚期癌症(NSCLC)患者的白蛋白水平与总生存率(OS)之间的非线性关系。具体而言,我们研究了传统线性分析可能无法捕捉到的潜在非线性关联。方法对211例接受安洛替尼治疗的晚期NSCLC患者进行回顾性队列研究。考虑了广泛的白蛋白水平,并应用GAM方法来解释潜在的混杂临床变量,揭示白蛋白和OS之间的非线性关系。结果在校正潜在的混杂因素后,白蛋白水平与OS之间呈非线性关系,拐点为40g/L和48g/L。拐点左侧、中间和右侧的风险比(HR)分别为0.95(95%置信区间[CI],0.87至1.04,p=0.2819,n=71)、0.75(95%可信区间,0.64至0.89,p=0.0007,n=133)和2.79(95%CI,1.39至5.61,p=0.0039,n=7)。研究结果表明,当白蛋白水平在40g/L至48g/L之间时,白蛋白水平与OS呈负相关。白蛋白每增加一个单位,死亡风险就会降低25%。亚组分析显示,这种负相关关系随着血尿素氮(BUN)水平的升高而增强,而随着D-二聚体的升高而减弱。结论血清白蛋白水平与OS呈非线性关系。白蛋白水平是OS的独立预后因素。此外,BUN水平和D-二聚体水平可以改变白蛋白水平对接受安洛替尼治疗的晚期NSCLC患者死亡风险的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
8.10
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信